Your contact person
Manager PR & Communications Jan Phillip Denkers
Boston Scientific to Acquire EndoChoice
Boston Scientific (NYSE: BSX) and EndoChoice Holdings, Inc. (NYSE: GI) today announced the companies have entered into a definitive agreement under which Boston Scientific ...
Read more …
altona Diagnostics’ RealStar® Zika Virus RT-PCR Kit 1.0 receives Emergency Use Authorization for Korea
altona Diagnostics GmbH, a diagnostic company headquartered in Hamburg, Germany, announced that it received Emergency Use Authorization (EUA) from the Korea Centers for Disease ...
Read more …
First Diagnostic Test for Zika virus accepted by WHO
RealStar® Zika Virus RT-PCR Kit 1.0 was listed by WHO as first in vitro diagnostic test eligible for procurement agencies and Member States. It ...
Read more …
Evotec awarded contract from Antibiotic Research UK to begin integrated drug discovery collaboration
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN DE0005664809) announced today a collaboration with Antibiotic Research UK ("ANTRUK") to identify alternative means of treating ...
Read more …
Proteo receives US$ 1 million grant for a new Elafin drug formulation
Proteo, Inc. (OTCQB: PTEO) announced today that its wholly-owned German subsidiary Proteo Biotech AG, a clinical stage pharmaceutical development company, has been awarded a ...
Read more …
Kobe and Life Science Nord on a joint mission
During a North German delegation’s visit to Japan, the cluster management organizations of the two regions signed an agreement to strengthen collaboration between companies ...
Read more …
BFCC Kick-Off Meeting in Hamburg
The Kick-Off Meeting of the Baltic Fracture Competence Centre (BFCC) took place on the 21st and 22nd of April in Hamburg. The BFCC is ...
Read more …
New Liquid Biopsy RAS Testing for Metastatic Colorectal Cancer Patients now Available for Clinical Practices
Sysmex Inostics, a subsidiary of Sysmex Corporation, announced that its OncoBEAM® RAS CRC test has been granted CE Mark approval. The test, developed by ...
Read more …
Topas Therapeutics Raises EUR 14 Million to Treat Immunological Disorders
Topas Therapeutics GmbH (“Topas”), a Hamburg/Germany based company, today announced the closing of its Series A financing round. This investment provides the company with ...
Read more …
New Leibniz Campus for Researching Lung Diseases Approved
The Leibniz Association has announced the establishment of three ScienceCampi in the university city of Kiel. This was decided by the Senate of the ...
Read more …
Excellent Science for New Therapies
Chronic inflammmation, triggered by dysfunctions on the boundary surfaces of the body’s organs and their interaction with the environment, represents a central challenge for ...
Read more …
Evotec achieves milestone in collaboration with Padlock Therapeutics
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced the achievement of a key pre-clinical milestone in the ongoing alliance with its ...
Read more …